When was Omzey founded?

Omzey was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Omzey located?

Omzey is headquartered in Rome, Italy.

Who is the current CEO of Omzey?

Simone Gardini of Omzey. They have also founded 1 company.

How many employees does Omzey have?

As of May 31, 2026, the latest employee count at Omzey is 38.

Is Omzey a funded company?

Omzey is a funded company, having raised a total of $1.63M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jun 01, 2018.

When was the latest funding round of Omzey?

Omzey's latest funding was a $***** Grant (prize money) round on Dec 01, 2022, with participation from 1 investor. Its primary sector is Healthcare IT. In Italy, the Healthcare IT sector has seen $29.1M in funding in 2026 to date.

Where does Omzey rank among its competitors?

Omzey ranks 76th amongst 781 active competitors, of which 111 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was IMU Biosciences, which secured an undisclosed amount in Jun, 2026.

Who are the top competitors of Omzey?

Omzey's top competitors include Benchling, Helix and Cellworks. Among them, IMU Biosciences secured the most recent funding round in June, 2026.

Omzey - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of diagnostics solutions to manage, and optimize genetics laboratory workflows. The company's product, JuliaOmix, cloud solution to support the complexity of genetics laboratory process that spans the genomic analysis cycle, from request to report, and clinical decision support.

Website: omzey.com
Social
Email ID: *****@genomeup.com

Key Metrics

Founded Year

2017

Location

Rome, Italy

Stage

Seed

Total Funding

$1.63M in 4 rounds

Latest Funding Round

Grant (prize money), Dec 01, 2022, $*****

Investors

Lumen Ventures & 9 more

Ranked

76^th among 781 active competitors

Employee Count

38 as on May 31, 2026

Similar Companies

Benchling & 955 more

View Omzey's full profile

Omzey has raised a total funding of $1.63M over 4 rounds. Its first funding round was on Jun 01, 2018. Its latest funding round was a Grant (prize money) round on Dec 01, 2022 for $*****. 1 investor participated in its latest round. Omzey has 10 institutional investors.

Here is the list of recent funding rounds of Omzey:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 01, 2022	2900968	Grant (prize money)	5329788	9286595	4108954	8011320
Feb 08, 2022	5034089	Seed	5956388	8713436	7118560	a\|impact & 3 more
Jul 20, 2018	8075437	Seed	2595858	3476197	7271515	Angel Partner Group & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Omzey's funding rounds and investors

The founders of Omzey are Alessandro Rossi and Simone Gardini. Simone Gardini is the CEO of Omzey.

Here are the details of Omzey's key team members:

Alessandro Rossi: Co-Founder of Omzey and founder of 1 other company.
Simone Gardini: Co-Founder & CEO of Omzey.
Contact Info: 1 email address

View details of Omzey's Founder profiles and Board Members

Omzey's employee count trend

Omzey has 38 employees as of May 26. Here is Omzey's employee count trend over the years:

Uncover Omzey's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Omzey include Benchling, Helix and Cellworks. Here is the list of Top 10 competitors of Omzey, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Altimeter Capital, Benchmark & 29 others	73/100
2nd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 13 others	71/100
3rd	Cellworks 2005, San Jose (United States), Series B	Developer of a biosimulation platform	$16.5M	Bering Capital, Artiman & 3 others	66/100
4th	Sophia Genetics 2011, Rolle (Switzerland), Public	Provider of artificial intelligence software for analyzing complex medical data	$249M	Generation Investment Management, Endeavour Vision ... & 25 others	62/100
5th	Latch 2021, San Francisco (United States), Series A	Provider of a web-based platform for genomic bioinformatics	$33M	Lux Capital, Coatue & 7 others	60/100
6th	Life Bit 2017, London (United Kingdom), Series B	AI and SaaS-based genomics analysis software for drug development	$70.9M	Tiger Global Management, Idinvest Partners ... & 13 others	57/100
7th	BostonGene 2015, Waltham (United States), Series B	Developer of cloud-based information and analytics platform to treat cancer	$200M	NEC, Japan Industrial Partners & 1 others	57/100
8th	Geneyx 2018, Herzliya (Israel), Seed	Provider of a clinical genetics data management platform for hospitals and genetic labs	$10M	Capri Ventures, Accenture & 5 others	57/100
9th	IMU Biosciences 2019, London (United Kingdom), Series A	Provider of immune discovery platform for precision medicines	$53M	Molten Ventures, IQ Capital & 4 others	56/100
10th	ICarbonX 2015, Shenzhen (China), Series D	Provider of bioinformatic platforms for health management and drug development	$366M	Wealthking Investments, China Investment Corporation ... & 11 others	55/100
76th	Omzey 2017, Rome (Italy), Seed	Provider of diagnostics solutions to manage, and optimize genetics laboratory workflows	$1.63M	LVenture Group, Europa & 8 others	38/100